Development and analytical performance of a new research use only (RUO) GP73 automated immunoassay
Golgi protein 73 (GP73) is a serum marker with potential applications in the assessment of chronic liver disease progression. We developed a research use only (RUO) GP73 immunoassay to detect serum GP73 concentration. A pair of internal antibodies that most effectively capture and detect GP73 were u...
Saved in:
| Main Authors: | Shaohua Ning, Enfu Liu, Fanju Meng, Fei Chen, James Hartnett, Zhihong Lin, Bailin Tu, David J. Hawksworth, Bryan C. Tieman, De Yu Mao, Ryan Piktel, Amit Kumar, You Pan, Philip M. Hemken |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Biochemistry and Biophysics Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580825000482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma
by: Qian Wang, et al.
Published: (2025-04-01) -
The use of biomarkers GP-73 and AFP in the early diagnosis of hepatocarcinoma associated with liver cirrhosis of HCV etiology
by: A. K. Bayjanov, et al.
Published: (2025-06-01) -
Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results
by: Hu Rui, et al.
Published: (2025-04-01) -
Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a
by: Tao ZY, et al.
Published: (2025-06-01) -
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
by: Shan Hong, et al.
Published: (2025-01-01)